New balloon catheters, wire guides target PAD

February 2010
Cardiology Today;Feb2010, Vol. 13 Issue 2, p18
The article reports on the launch of several interventional products designed to treat peripheral artery disease at the Vascular Interventional Advances 2009 meeting in Las Vegas, Nevada.


Related Articles

  • New laser for treatment of vascular lesions.  // Dermatology Times;Apr2006, Vol. 27 Issue 4, p99 

    The article evaluates WaveLight Laser Technologies AG's IDAS laser system and offers information on its use for treating superficial vascular lesions which include rosacea and telangiectasias.

  • Covidien's TurboHawk PAD excision system launched. FORD, OMAR // Medical Device Daily;2/18/2011, Vol. 15 Issue 34, p1 

    The article focuses on the TurboHawk plaque excision system developed by Covidien. The system is capable of not only cutting into both hard and soft plaque in the leg arteries in patients with peripheral arterial disease (PAD) but also removing buildup from the entire body. It notes on the...

  • Endovenous Occlusion Offers Alternative to Surgical Vein Stripping. Guttman, Cheryl // Dermatology Times;Feb99, Vol. 20 Issue 2, p12 

    Focuses on the use of radiofrequency endovenous occlusion as an alternative to surgical vein stripping for treating insufficiency of saphenous and other superficial system veins. Description of the technique; Preclinical studies of the technique; Level of tolerance to the procedure.

  • Mark My Words. Kelly, Barry // Ulster Medical Journal;Jan2011, Vol. 80 Issue 1, p1 

    The article discusses various reports published within the issue including one by David Edgar about immunology, Patrick Morrison's article on gigantism and Mark O'Donnell et al on the optimal management of peripheral vascular disease for the non-specialist.

  • Erratum to Acrocyanosis: The Flying Dutchman.  // Vascular Medicine;Oct2011, Vol. 16 Issue 5, p409 

    The Publishers would like to apologise for the printing error in Acrocyanosis: The Flying Dutchman by Andrew K Kurklinsky, Virginia M Miller and Thom W Rooke, DOI: 10.1177/1358863X11398519.Published in Vascular Medicine 16(4) 288–301.

  • ABBS effective as ACE?  // Critical Care Alert;Jun2008 Pharmacology Watch, p1 

    The article presents a discussion of the effectiveness of angiotensin-receptor blockers (ARBs), examining whether they are as effective in reducing vascular events among high-risk patients as angiotensin-converting-enzyme (ACE) inhibitors.

  • Editorial. Creager MD, M.A.; Anand, S.S. // Vascular Medicine;2001, Vol. 6 Issue 1, p1 


  • Reversing Heart disease in the New Millennium. Fleming, Richard M. // Angiology;Aug2000, Vol. 51 Issue 8, p617 

    Determines the effect of treatment based on an immunologic unified theory of vascular disease. Quantifying the extent and severity of coronary artery disease; Assessment of wall motion abnormalities and ejection fraction by both nuclear and echocardiographic methods; Components of treatment.

  • Isosorbide Mononitrate 30% Immediate-Release 70% Sustained-Release Formulation: A Review. Cleophas, Ton J.; Niemeyer, Menco G.; Zwinderman, Aeilko H.; van der Wall, Ernst E. // Angiology;Aug2000, Vol. 51 Issue 8, p631 

    Focuses on the clinical efficacy and safety of isosorbide mononitrate immediate-release sustained-release (IR-SR) formulation to see whether theoretical advantages translate into better clinical effectiveness. Formulations advantage over conventional isosorbide mononitrate or dinitrate; Rapid...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics